Cancer Treatments Are Going To Be Changing In The Near Future With Eric Lefkofsky’s Tempus Technology
Eric Lefkofsky earned his degree in 1991 from the University of Michigan, followed by earning his Juris Doctor degree from law school. Along with earning his degrees and building an impressive academic background, Eric Lefkofsky also has the mind of an entrepreneur, as he has started up several successful companies that have contributed to his vast amount of success and his fortune. Most people have heard of his app Groupon, which offers coupons to people so they can save money when they go out to eat and travel. Eric Lefkofsky’s latest efforts in business following his academic background is Tempus. This company will focus on genomic sequencing and amassing data from throughout the medical field to improve research and create precise treatments for cancer patients.
The foundation of Tempus lies in analytics software that will allow the company to compile that vast amounts of loose data around the world in healthcare service and cancer. Eric Lefkofsky says that the disorganization of data in the healthcare industry is massive and leaves treatments, especially related to cancer, to generalized for each patient.
Eric is not only the Co-founder of Tempus, he also works alongside his wife managing the Lefkofsky foundation. On top of this, Eric manages other businesses and is a member for several other organizations as a member of the board. In his spare time, he also gives speeches to teach students about business and tech as well as being an entrepreneur.
When it comes to the world of technology, things are always advancing. The same thing can be said of the healthcare industry. Despite that, however, there is a challenge in the healthcare industry for providing patients with proper and specialized care that has been accurately created to fit each patient’s needs. Eric Lefkofsky is creating a solution for that problem through Tempus alongside Co-founder Brad Keywell. As Tempus continues to compile data from the field of healthcare around the world, the healthcare practice as a whole will be aided with more specific and accurate data for treatments.
About Eric Lefkofsky: www.crunchbase.com/person/eric-lefkofsky